Table of Contents Author Guidelines Submit a Manuscript
BioMed Research International
Volume 2016, Article ID 8086398, 9 pages
http://dx.doi.org/10.1155/2016/8086398
Research Article

Assessment of the Number and Phenotype of Macrophages in the Human BMB Samples of CML

1Department of Clinical Laboratory, Yunnan Provincial First People’s Hospital, Kunming, Yunnan 650032, China
2Institute of Clinical and Basic Medical Sciences, Yunnan Provincial First People’s Hospital, Kunming, Yunnan 650032, China
3Department of Hematology, Yunnan Provincial First People’s Hospital, Kunming, Yunnan 650032, China

Received 8 August 2016; Revised 24 October 2016; Accepted 3 November 2016

Academic Editor: Paul M. Tulkens

Copyright © 2016 Jian-Xin Song et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. S. Soverini, C. De Benedittis, M. Mancini, and G. Martinelli, “Best practices in chronic myeloid leukemia monitoring and management,” The Oncologist, vol. 21, no. 5, pp. 626–633, 2016. View at Publisher · View at Google Scholar
  2. S. Mukherjee and M. Kalaycio, “Accelerated phase CML: outcomes in newly diagnosed vs. Progression from chronic phase,” Current Hematologic Malignancy Reports, vol. 11, no. 2, pp. 86–93, 2016. View at Publisher · View at Google Scholar
  3. K. Machová Polaková, T. Lopotová, H. Klamová et al., “Expression patterns of microRNAs associated with CML phases and their disease related targets,” Molecular Cancer, vol. 10, article 41, 2011. View at Publisher · View at Google Scholar · View at Scopus
  4. L. Chiossone, R. Conte, G. M. Spaggiari et al., “Mesenchymal stromal cells induce peculiar alternatively activated macrophages capable of dampening both innate and adaptive immune responses,” Stem Cells, vol. 34, no. 7, pp. 1909–1921, 2016. View at Publisher · View at Google Scholar
  5. F. Peyrusson, D. Butler, P. M. Tulkens, and F. Van Bambeke, “Cellular pharmacokinetics and intracellular activity of the novel peptide deformylase inhibitor GSK1322322 against Staphylococcus aureus laboratory and clinical strains with various resistance phenotypes: studies with human THP-1 monocytes and J774 murine macrophages,” Antimicrobial Agents and Chemotherapy, vol. 59, no. 9, pp. 5747–5760, 2015. View at Publisher · View at Google Scholar · View at Scopus
  6. M. Rath, I. Müller, P. Kropf, E. I. Closs, and M. Munder, “Metabolism via arginase or nitric oxide synthase: two competing arginine pathways in macrophages,” Frontiers in Immunology, vol. 5, article 532, 2014. View at Publisher · View at Google Scholar · View at Scopus
  7. Y. Liu, K. Chen, C. Wang et al., “Cell surface receptor FPR2 promotes antitumor host defense by limiting M2 polarization of macrophages,” Cancer Research, vol. 73, no. 2, pp. 550–560, 2013. View at Publisher · View at Google Scholar · View at Scopus
  8. M. Cieslewicz, J. Tang, J. L. Yu et al., “Targeted delivery of proapoptotic peptides to tumor-associated macrophages improves survival,” Proceedings of the National Academy of Sciences of the United States of America, vol. 110, no. 40, pp. 15919–15924, 2013. View at Publisher · View at Google Scholar
  9. X. Tang, C. Mo, Y. Wang, D. Wei, and H. Xiao, “Anti-tumour strategies aiming to target tumour-associated macrophages,” Immunology, vol. 138, no. 2, pp. 93–104, 2013. View at Publisher · View at Google Scholar · View at Scopus
  10. Y. Komohara, M. Jinushi, and M. Takeya, “Clinical significance of macrophage heterogeneity in human malignant tumors,” Cancer Science, vol. 105, no. 1, pp. 1–8, 2014. View at Publisher · View at Google Scholar · View at Scopus
  11. M. Heusinkveld and S. H. van der Burg, “Identification and manipulation of tumor associated macrophages in human cancers,” Journal of Translational Medicine, vol. 9, no. 1, article 216, 2011. View at Publisher · View at Google Scholar · View at Scopus
  12. Y. Komohara, Y. Fujiwara, K. Ohnishi, D. Shiraishi, and M. Takeya, “Contribution of macrophage polarization to metabolic diseases,” Journal of Atherosclerosis and Thrombosis, vol. 23, no. 1, pp. 10–17, 2016. View at Publisher · View at Google Scholar · View at Scopus
  13. F. O. Martinez, L. Helming, R. Milde et al., “Genetic programs expressed in resting and IL-4 alternatively activated mouse and human macrophages: similarities and differences,” Blood, vol. 121, no. 9, pp. e57–e69, 2013. View at Publisher · View at Google Scholar · View at Scopus
  14. K. Kambara, W. Ohashi, K. Tomita et al., “In vivo depletion of CD206+ M2 macrophages exaggerates lung injury in endotoxemic mice,” American Journal of Pathology, vol. 185, no. 1, pp. 162–171, 2015. View at Publisher · View at Google Scholar · View at Scopus
  15. J. Thiele, H. M. Kvasnicka, D. W. Beelen et al., “Macrophages and their subpopulations following allogeneic bone marrow transplantation for chronic myeloid leukaemia,” Virchows Archiv, vol. 437, no. 2, pp. 160–166, 2000. View at Publisher · View at Google Scholar · View at Scopus
  16. S. K. Biswas and A. Mantovani, “Macrophage plasticity and interaction with lymphocyte subsets: cancer as a paradigm,” Nature Immunology, vol. 11, no. 10, pp. 889–896, 2010. View at Publisher · View at Google Scholar · View at Scopus
  17. J. Thiele, C. Braeckel, S. Wagner et al., “Macrophages in normal human bone marrow and in chronic myeloproliferative disorders: an immunohistochemical and morphometric study by a new monoclonal antibody (PG-M1) on trephine biopsies,” Virchows Archiv A—Pathological Anatomy and Histopathology, vol. 421, no. 1, pp. 33–39, 1992. View at Publisher · View at Google Scholar · View at Scopus
  18. Y. Komohara, K. Ohnishi, J. Kuratsu, and M. Takeya, “Possible involvement of the M2 anti-inflammatory macrophage phenotype in growth of human gliomas,” Journal of Pathology, vol. 216, no. 1, pp. 15–24, 2008. View at Publisher · View at Google Scholar · View at Scopus
  19. Y. Komohara, D. Niino, K. Ohnishi, K. Ohshima, and M. Takeya, “Role of tumor-associated macrophages in hematological malignancies,” Pathology International, vol. 65, no. 4, pp. 170–176, 2015. View at Publisher · View at Google Scholar · View at Scopus
  20. D. Duluc, Y. Delneste, F. Tan et al., “Tumor-associated leukemia inhibitory factor and IL-6 skew monocyte differentiation into tumor-associated macrophage-like cells,” Blood, vol. 110, no. 13, pp. 4319–4330, 2007. View at Publisher · View at Google Scholar · View at Scopus
  21. A. Georgii, K. F. Vykoupil, T. H. Buhr et al., “Chronic myeloproliferative disorders in bone marrow biopsies,” Pathology Research and Practice, vol. 186, no. 1, pp. 3–27, 1990. View at Publisher · View at Google Scholar · View at Scopus
  22. G. Büsche, H. Majewski, J. Schlué et al., “Frequency of pseudo-Gaucher cells in diagnostic bone marrow biopsies from patients with Ph-positive chronic myeloid leukaemia,” Virchows Archiv, vol. 430, no. 2, pp. 139–148, 1997. View at Publisher · View at Google Scholar · View at Scopus
  23. Y. Saito, Y. Komohara, D. Niino et al., “Role of CD204-positive tumor-associated macrophages in adult T-cell leukemia/lymphoma,” Journal of Clinical and Experimental Hematopathology, vol. 54, no. 1, pp. 59–65, 2014. View at Publisher · View at Google Scholar · View at Scopus
  24. P. J. Murray and T. A. Wynn, “Protective and pathogenic functions of macrophage subsets,” Nature Reviews Immunology, vol. 11, no. 11, pp. 723–737, 2011. View at Publisher · View at Google Scholar · View at Scopus
  25. F. Ginhoux, J. L. Schultze, P. J. Murray, J. Ochando, and S. K. Biswas, “New insights into the multidimensional concept of macrophage ontogeny, activation and function,” Nature Immunology, vol. 17, no. 1, pp. 34–40, 2016. View at Publisher · View at Google Scholar · View at Scopus
  26. M. M. Mohamed, E. A. El-Ghonaimy, M. A. Nouh, R. J. Schneider, B. F. Sloane, and M. El-Shinawi, “Cytokines secreted by macrophages isolated from tumor microenvironment of inflammatory breast cancer patients possess chemotactic properties,” International Journal of Biochemistry and Cell Biology, vol. 46, no. 1, pp. 138–147, 2014. View at Publisher · View at Google Scholar · View at Scopus
  27. K. Suzuki, R. Sun, M. Origuch et al., “Mesenchymal stromal cells promote tumor growth through the enhancement of neovascularization,” Molecular Medicine, vol. 17, no. 7-8, pp. 579–587, 2011. View at Publisher · View at Google Scholar · View at Scopus
  28. D. S. Krause, K. Fulzele, A. Catic et al., “Differential regulation of myeloid leukemias by the bone marrow microenvironment,” Nature Medicine, vol. 19, no. 11, pp. 1513–1517, 2013. View at Publisher · View at Google Scholar · View at Scopus
  29. T. Salim, C. L. Sershen, and E. E. May, “Investigating the role of TNF-α and IFN-γ activation on the dynamics of iNOS gene expression in LPS stimulated macrophages,” PLoS ONE, vol. 11, no. 6, Article ID e0153289, 2016. View at Publisher · View at Google Scholar
  30. O. M. Pello, M. De Pizzol, M. Mirolo et al., “Role of c-MYC in alternative activation of human macrophages and tumor-associated macrophage biology,” Blood, vol. 119, no. 2, pp. 411–421, 2012. View at Publisher · View at Google Scholar · View at Scopus
  31. I. N. Buhtoiarov, P. M. Sondel, J. M. Wigginton et al., “Anti-tumour synergy of cytotoxic chemotherapy and anti-CD40 plus CpG-ODN immunotherapy through repolarization of tumour-associated macrophages,” Immunology, vol. 132, no. 2, pp. 226–239, 2011. View at Publisher · View at Google Scholar · View at Scopus
  32. Y. Fujiwara, M. Takeya, and Y. Komohara, “A novel strategy for inducing the antitumor effects of triterpenoid compounds: Blocking the protumoral functions of tumor-associated macrophages via stat3 inhibition,” BioMed Research International, vol. 2014, Article ID 348539, 11 pages, 2014. View at Publisher · View at Google Scholar · View at Scopus
  33. C. Ngambenjawong, M. Cieslewicz, J. G. Schellinger, and S. H. Pun, “Synthesis and evaluation of multivalent M2pep peptides for targeting alternatively activated M2 macrophages,” Journal of Controlled Release, vol. 224, pp. 103–111, 2016. View at Publisher · View at Google Scholar · View at Scopus
  34. D. Duluc, M. Corvaisier, S. Blanchard et al., “Interferon-γ reverses the immunosuppressive and protumoral properties and prevents the generation of human tumor-associated macrophages,” International Journal of Cancer, vol. 125, no. 2, pp. 367–373, 2009. View at Publisher · View at Google Scholar · View at Scopus
  35. C. Baer, M. L. Squadrito, D. Laoui et al., “Suppression of microRNA activity amplifies IFN-γ-induced macrophage activation and promotes anti-tumour immunity,” Nature Cell Biology, vol. 18, no. 7, pp. 790–802, 2016. View at Publisher · View at Google Scholar
  36. K. Hatogai, S. Kitano, S. Fujii et al., “Comprehensive immunohistochemical analysis of tumor microenvironment immune status in esophageal squamous cell carcinoma,” Oncotarget, 2016. View at Publisher · View at Google Scholar
  37. S. Lemaire, M.-P. Mingeot-Leclercq, P. M. Tulkens, and F. Van Bambeke, “Study of macrophage functions in murine J774 cells and human activated THP-1 cells exposed to oritavancin, a lipoglycopeptide with high cellular accumulation,” Antimicrobial Agents and Chemotherapy, vol. 58, no. 4, pp. 2059–2066, 2014. View at Publisher · View at Google Scholar · View at Scopus
  38. F. Ginhoux and M. Guilliams, “Tissue-resident macrophage ontogeny and homeostasis,” Immunity, vol. 44, no. 3, pp. 439–449, 2016. View at Publisher · View at Google Scholar
  39. E. Gomez Perdiguero, K. Klapproth, C. Schulz et al., “Tissue-resident macrophages originate from yolk-sac-derived erythro-myeloid progenitors,” Nature, vol. 518, no. 7540, pp. 547–551, 2015. View at Publisher · View at Google Scholar · View at Scopus
  40. S. Epelman, K. J. Lavine, and G. J. Randolph, “Origin and functions of tissue macrophages,” Immunity, vol. 41, no. 1, pp. 21–35, 2014. View at Publisher · View at Google Scholar · View at Scopus
  41. A. Dey, J. Allen, and P. A. Hankey-Giblin, “Ontogeny and polarization of macrophages in inflammation: blood monocytes versus tissue macrophages,” Frontiers in Immunology, vol. 5, article 683, 2014. View at Publisher · View at Google Scholar · View at Scopus
  42. R. Gentek, K. Molawi, and M. H. Sieweke, “Tissue macrophage identity and self-renewal,” Immunological Reviews, vol. 262, no. 1, pp. 56–73, 2014. View at Publisher · View at Google Scholar · View at Scopus
  43. R. A. Franklin and M. O. Li, “Ontogeny of tumor-associated macrophages and its implication in cancer regulation,” Trends Cancer, vol. 2, no. 1, pp. 20–34, 2016. View at Publisher · View at Google Scholar